PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Growth of biofuel industry hurt by GMO regulations

2010-10-02
(Press-News.org) CORVALLIS, Ore. – Faster development of the promising field of cellulosic biofuels – the renewable energy produced from grasses and trees – is being significantly hampered by a "deep and thorny regulatory thicket" that makes almost impossible the use of advanced gene modification methods, researchers say.

In a new study published today in the journal BioScience, scientists argue that major regulatory reforms and possibly new laws are needed to allow cellulosic bioenergy to reach its true potential as a form of renewable energy, and in some cases help reduce greenhouse gas emissions that cause global warming.

"It's extraordinary that gene modification technology, which has been adapted more rapidly than any other technology in the history of agriculture, and had some profound environmental and economic benefits, has been regulated virtually out of existence for perennial cellulosic biofuels crops," said Steve Strauss, a distinguished professor of forest biotechnology at Oregon State University, and lead author of the paper.

In the report, the authors noted that exotic plant species pose a serious risk of spread and ecosystem impacts, but face much less stringent regulation or obstacles than genetically engineered crops, which are carefully designed to solve problems, not cause them.

A genetically modified plant in which one or a few genes have been changed is treated as more of a risk than an invasive species that has thousands of new genes, and as a result is often resistant to multiple pests and has novel adaptive traits such as drought and heat tolerance, they said.

Companies that have the technical expertise to conduct advanced research have been forced to stay away from gene modification methods, rather than adopt them to speed breeding progress and insert novel traits important to the growing biofuels industry.

Traits that could be improved with gene modification include enhanced stress tolerance, reduced costs of conversion to liquid fuels, reduced use of water and fertilizer in cultivation, avoiding dispersal into the environment, and synthesis of new, renewable products such as industrial enzymes.

But virtually none of that potential is now being developed, they said.

The current environment poses enormous legal risks that can and have cost some companies millions of dollars in civil lawsuits, the scientists said, sometimes for damages that were more of perception and market issues, than of safety or environmental impact.

"Even research on traits expressly intended to reduce environmental impacts face the same legal risks and regulatory barriers as other traits," Strauss said. "Our own federally-funded research on means to promote ecological containment of gene-modified and exotic biofuel crops has been brought to a standstill by regulations."

The scientists said that the end result of a gene modification project – the trait produced, and whether it is safe and beneficial or not – should be the primary consideration for regulation, not the process used to produce it. Low-level risk and high benefit projects should be identified and allowed to move forward with much less stringent regulation or none at all. They also made several other suggestions for reform to make the overall system less slow, costly and uncertain.

"It is essential that we create an intelligent regulatory system that does not indiscriminately penalize the gene modification process and obstruct essential field research," Strauss said. "The one-size-fits-all style system of today treats the process of genetic modification as inherently dangerous, although many high-level science panels have concluded that the process is at least as safe as conventional breeding methods."

In some cases, the stringent regulations make it virtually impossible to do the very research needed to adequately understand issues of value and safety, the researchers said.

"The regulations in place, forthcoming, and those that have been imposed by legal actions result in the presumption that all forms of gene modified trees and grasses are 'plant pests' or 'noxious weeds' until extensive experimentation and associated documentation 'prove' otherwise," the scientists wrote in their report.

Solving these problems will require new ways of thinking and strong scientific and political leadership to create a regulatory system that enables, rather than arbitrarily blocks, the use of gene modification as a tool to accelerate and diversify the breeding of perennial biofuel crops, the researchers concluded.

###

Editor's Note: Strauss is in transit from international travel from Oct. 1-3, but will try to respond to email inquiries as possible. He will be available at the listed phone and email contacts on and after Oct. 4.

END



ELSE PRESS RELEASES FROM THIS DATE:

Researchers engineer adult stem cells that do not age

Researchers engineer adult stem cells that do not age
2010-10-02
BUFFALO, N.Y. -- Biomedical researchers at the University at Buffalo have engineered adult stem cells that scientists can grow continuously in culture, a discovery that could speed development of cost-effective treatments for diseases including heart disease, diabetes, immune disorders and neurodegenerative diseases. UB scientists created the new cell lines – named "MSC Universal" – by genetically altering mesenchymal stem cells, which are found in bone marrow and can differentiate into cell types including bone, cartilage, muscle, fat, and beta-pancreatic islet cells. ...

Mayo Clinic review of ethical decision making with end-of-life care

2010-10-02
ROCHESTER, Minn. -- In a review article published in the October issue of Mayo Clinic Proceedings,(http://www.mayoclinicproceedings.com) Mayo Clinic physicians differentiate the ethical and legal permissibility of withholding or withdrawing life-sustaining treatments and accepted comfort measures, specifically palliative sedation, from that of physician-assisted suicide or euthanasia. Physician reviewers find that palliative sedation has an important place on the continuum of appropriate palliative care. "At the end of life, patient goals often shift to comfort, and removal ...

Climate change forcing a 'move it or lose it' approach to species conservation?

2010-10-02
What does it take to save a species in the 21st century? The specter of climate change, with predicted losses to biodiversity as high as 35 percent, has some scientists and managers considering taking their conservation strategies on the road. Managed relocation (MR) is literally the physical relocation of endangered or threatened species of plants and animals, by humans, to new, and foreign geographical climes. It addresses the concern that climate shifts may make many species' historical ranges environmentally inhospitable, and that the rapid speed of change and habitat ...

GOES-13 sees an unholy matrimony: Nicole and low pressure swamp the US East Coast

GOES-13 sees an unholy matrimony: Nicole and low pressure swamp the US East Coast
2010-10-02
In a "marriage" that U.S. east coast residents would object to, the remnants of Tropical Storm Nicole coupled with an upper level low pressure area have dumped record rainfall from the Carolinas to New England on Sept. 30. The GOES-13 Satellite captured that massive "union" of a system as it begins to push off the northeastern U.S. coast today, Oct. 1. At 1401 UTC (10:01 a.m. EDT) on Oct. 1, the Geostationary Operational Environmental Satellite called GOES-13 captured a visible image of the extensive cloud cover of this coupled system. The GOES image shows the system's ...

NASA's Webb telescope MIRI instrument takes one step closer to space

NASAs Webb telescope MIRI instrument takes one step closer to space
2010-10-02
A major instrument due to fly aboard NASA's James Webb Space Telescope is getting its first taste of space in the test facilities at the Rutherford Appleton Laboratory (RAL) in the United Kingdom. The Mid-InfraRed Instrument (MIRI) has been designed to contribute to areas of investigation as diverse as the first light in the early Universe and the formation of planets around other stars. "The start of space simulation testing of the MIRI is the last major engineering activity needed to enable its delivery to NASA. It represents the culmination of 8 years of work by the ...

Computer-aided detection is increasingly being used in screening and diagnostic mammography

2010-10-02
The use of computer-aided detection (CAD) is increasing, in both screening and diagnostic mammography, according to a study in the October issue of the Journal of the American College of Radiology (www.jacr.org). CAD software systems highlight and alert the radiologist of abnormal areas of density, mass or calcification on a digitized mammographic image (of the breast) that may indicate the presence of cancer. Screening mammography is an X-ray exam of the breast that is used as a screening tool to detect early breast cancer in women experiencing no symptoms. Diagnostic ...

Measuring productivity helps radiology department improve efficiency

2010-10-02
Researchers working in a radiology department at a mid-sized hospital were able to increase productivity and improve efficiency by developing a simple method for measuring general technologist productivity, according to a study in the October issue of the Journal of the American College of Radiology (www.jacr.org). "Improving productivity and maintaining team spirit are often competing priorities that may be difficult to achieve simultaneously," said C. Daniel Johnson, MD, co-author of the study. "In an era of cost reductions, radiology departments need to be able to ...

October 2010 Geosphere highlights

2010-10-02
Boulder, CO, USA - This month's themed issue, "Advances in 3D imaging and analysis of geomaterials," edited by Guilherme A.R. Gualda, Don R. Baker, and Margherita Polacci, features papers from the 2009 AGU Joint Assembly session "Advances in 3-D Imaging and Analysis of Rocks and Other Earth Materials." Studies include 3-D imaging and analysis techniques for Wild 2 comet material returned from the NASA Stardust mission and the first 3-D X-ray scans of crystals from the Dry Valleys, Antarctica. Introduction: Advances in 3D imaging and analysis of geomaterials Guilherme ...

Evaluation of targeted therapy in ovarian cancer

2010-10-02
Reston, Va.— Research reported in the October issue of The Journal of Nuclear Medicine (JNM) shows that a molecular imaging technique may prove useful in early assessment of treatment response for cisplatin-resistant ovarian cancer. "One of the most promising aspects of molecular imaging is its potential capacity to measure therapy effects long before changes in the tumor size and shape are detected," said Marijke De Saint-Hubert, medical scientist in the Department of Nuclear Medicine at the University Hospital Gasthuisberg, Leuven, Belgium, and one of the authors on ...

Parkinson's disease: Excess of special protein identified as key to symptoms and possible new target for treatment with widely used anti-cancer drug imatinib

2010-10-02
Johns Hopkins scientists have discovered that the over-activation of a single protein may shut down the brain-protecting effects of a molecule and facilitate the most common form of Parkinson's disease. The finding of this mechanism could lead to important new targets for drugs already known to inhibit it, thus controlling symptoms of the disorder, which affects about 1 million older Americans. Previous research demonstrated that a protein called parkin protects brain cells by "tagging" certain toxic elements that are then destroyed naturally. It was also known that ...

LAST 30 PRESS RELEASES:

Antimicrobial effects of Syzygium aromaticum and Salvadora persica against common peri-implantitis pathogens in vitro

EVs pose no greater risk to pedestrians than conventional vehicles

Modeling microplastic accumulation under the ocean surface

Pompeii offers insights into ancient Roman building technology

University of Utah engineers give a bionic hand a mind of its own

Transient and long-term risks of common physical activities in people with low back pain

Health care contact days in older adults with metastatic cancer

Brain resilience science reshapes psychiatry from treating illness to building strength

An assessment of the antidepressant potential of deramciclane in two animal tests

Pitt and UPMC study finds epigenetic signature of pediatric traumatic brain injury, paves way for precision recovery tools

Brain discovery opens door to earlier detection of metabolic syndrome in women

SwRI-led study provides insight into oscillations in solar flares

Announcing the third cohort of the Hevolution/AFAR new investigator awards in aging biology and geroscience research

GeoFlame VISION: Using AI and satellite imagery to predict future wildfire risk

Nationwide study suggests that water treatment methods may impact the risk of legionnaires’ disease

Oyster larvae on drugs move slowly and are stressed

Targeting a specific brain circuit may help prevent opioid relapse, WSU study finds

Tec-Dara combination offers substantial improvement over standard second-line therapies for relapsed or refractory multiple myeloma

Improving treatment for an autoimmune bleeding condition

Drug reduced need for blood transfusions during hospitalization for non-cardiac surgery

Novel agent ianalumab added to standard therapy extends time to treatment failure in patients with previously treated immune thrombocytopenia

Pirtobrutinib outperforms bendamustine plus rituximab for previously untreated CLL/SLL

Online tracking and privacy on hospital websites

A freely available tool to document wartime destruction

Residential solar panels can raise electricity rates

Scientists use synthetic platelets as ‘Trojan horse’ drug-delivery system

Cooperative Intermolecular Interactions Regulate Supramolecular Polymer Assembly

Korea University researchers develop ultrasensitive method to detect low-frequency cancer mutations

First patient enrolled in GOG-3133/ FRAmework-01 phase 3 study evaluating sofetabart mipitecan (LY4170156), a novel ADC targeting folate receptor alpha (FRα), in recurrent ovarian cancer

Two Hebrew University researchers win prestigious ERC consolidator grants

[Press-News.org] Growth of biofuel industry hurt by GMO regulations